CRP and neoplasm: Concerning its pro-inflammatory activity, higher serum levels of CRP have been linked to the overall and progression-free survival of patients with ovarian cancer, with a close relationship between the levels of CRP, tumor aggressiveness, and disease progression in these patients (38).